Disc Medicine (IRON) Operating Income (2020 - 2026)
Disc Medicine (IRON) reported Operating Income of -$69.5 million for Q1 2026, down 74.04% year-over-year from -$267.9 million in Q1 2025, and down 3.81% quarter-over-quarter from -$67.0 million in Q4 2025.
Disc Medicine (IRON) Operating Income (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Operating Income data on file, last reported at -$69.5 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$69.5 million, down 74.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$265.6 million (down 92.18% YoY), and the FY2025 annual result was -$236.0 million, down 81.95% from the prior year.
- Operating Income slipped to -$69.5 million in Q1 2026 per IRON's latest filing, from -$67.0 million in the prior quarter.
- Over five years, Operating Income peaked at -$10.0 million in Q1 2022 and troughed at -$69.5 million in Q1 2026.
- A 5-year average of -$33.8 million and a median of -$30.9 million in 2024 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 43.2% in 2022 and fell as far as 173.9% in 2022.
- A 5-year view of Operating Income shows it stood at -$15.0 million in 2022, then plunged by 97.82% to -$29.7 million in 2023, then declined by 16.28% to -$34.6 million in 2024, then sank by 93.84% to -$67.0 million in 2025, then slipped by 3.81% to -$69.5 million in 2026.
- Business Quant data shows IRON's Operating Income at -$69.5 million in Q1 2026, -$67.0 million in Q4 2025, and -$67.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | -69.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.52 Mn |
| Dec 31, 2025 | -66.97 Mn |
| Sep 30, 2025 | -67.70 Mn |
| Jun 30, 2025 | -61.41 Mn |
| Mar 31, 2025 | -39.95 Mn |
| Dec 31, 2024 | -34.55 Mn |
| Sep 30, 2024 | -32.86 Mn |
| Jun 30, 2024 | -30.85 Mn |
| Mar 31, 2024 | -31.46 Mn |
| Dec 31, 2023 | -29.71 Mn |
| Sep 30, 2023 | -18.96 Mn |
| Jun 30, 2023 | -17.33 Mn |
| Mar 31, 2023 | -25.13 Mn |
| Dec 31, 2022 | -15.02 Mn |
| Sep 30, 2022 | -10.48 Mn |
| Jun 30, 2022 | -12.02 Mn |
| Mar 31, 2022 | -9.96 Mn |
| Dec 31, 2021 | 20.33 Mn |
| Sep 30, 2021 | -18.45 Mn |
| Jun 30, 2021 | -16.32 Mn |